66 / 112
64
WFSBP 2015
Scientific Programme
|
Wednesday, 17 June 2015
FC-14-003
Persistence of psychotic symptoms as an indicator of cog-
nitive impairment in methamphetamine users
Chih-Ken Chen, Taiwan
S.-K. Lin, M.-C. Huang, Y.-C. Chen, L.-J. Wang
FC-14-004
Addiction: The burden of cyclothymic temperament
Andreas Erfurth, Austria
G. Sachs, O. Lesch
FC-14-005
Aerobic exercise as treatment for tobacco cravings in college
students who are quitting smoking
Carmen Lara, Mexico
M. T. Baez, A. Reyes
FC-14-006
Perceived pain, dissociation and its relation to history of
sexual abuse among methadone maintenance and non-ad-
dicted patients
Einat Peles, Israel
Z. Seligman, D. Potik, M. Bloch, A. Sason, S. Schreiber,
M. Adelson
FC-15
Free Communications
08:30–10:00
Conference Room 1
Anxiety Disorders
Chair:
Michel Bourin, France
Co-Chair: Nikos Vaidakis, Greece
FC-15-001
Patterns of salivary cortisol level in anxiety disorders and
personality disorders and changes in salivary cortisol level
after psychotherapy
Edyta Dembiñska, Poland
K. Rutkowski, K. Tokarz, J. Sobanski, K. Cyranka, L. Muld-
ner-Nieckowski, M. Mielimaka
FC-15-003
Obsessive symptoms and clozapine
Esteban Rodríguez Jiménez, Spain
J. Alcalá Partera, M. d. Pino Ordovás González, A. Benito
Duarte
FC-15-004
Tau protein is important for stress-driven depressive pa-
thology and cognitive deficits
Ioannis Sotiropoulos, Portugal
S. Lopes, J. Vaz Silva, S. Rodrigues, J. Silva, V. Pinto, N. Ko-
kras, B. Benenk, M. Czisch, O. Almeida, C. Dalla, N. Sousa
FC-15-005
Hair cortisol and subjective stress in patients with schizo-
phrenia and bipolar disorder
Lejla Hasandedi, Germany
F. Streit, A. Memic, J. Strohmaier, J. Frank, M. Lang, S. H.
Witt, A. Forstner, F. Degenhardt, M. Nöthen, C. Kirschbaum,
L. Oruc, M. Rietschel
FC-15-006
Can body dysmorphic disorder be classifed an obsessive
spectrum disorder? Evidence from neuroimaging
Susan Rossell, Australia
B. Buchanan, J. Maller, W. L. Toh, D. Castle
FC-16
Free Communications
15:00–16:30
Kokkali Room
Liaison Psychiatry
Chair:
Ladislav Hosak, Czech Republic
Co-Chair: Thomas Paparrigopoulos, Greece
FC-16-001
Utilization and predictors of post-stroke antidepressant
treatment
Janne Kaergaard Mortensen, Denmark
S. P. Johnsen, H. Larsson, G. Andersen
FC-16-002
Depressive disorders in patients with coronary heart dis-
ease associated with arterial hypertension and metabolic
disorders of carbohydrate and fat metabolism
Alexander Rozin, Russia
E. Schastnyy, N. Garganeeva
FC-16-003
Vitamin D supplementation reduces depressive symptoms
in patients with chronic liver disease
Caroline Stokes, Germany
F. Gruenhage, C. Baus, D. Volmer, S. Wagenpfeil, M. Rie-
menschneider, F. Lammert
FC-16-004
Parkinson‘s disease depression, the pieces of the puzzle:
Suggestions for a practical approach
Emmanuelle Pourcher, Canada
FC-16-005
The role of consultation-liaison psychiatrist in preventing,
identifying and treating Wernicke‘s encephalopathy
Magdalena Spariosu, USA
D. Coira, C. Wassef, J. Emolo
FC-16-006
Executive dysfunction in psychosis following traumatic
brain injury
Rachel Batty, Australia
A. Francis, N. Thomas, M. Hopwood, J. Ponsford, S. Rossell